Latest From Biotech Now

Academics to be Featured at the 2013 BIO Alliance Pavilion

BIO International Convention

I think it safe to say that the U.S. biotechnology industry has its R&D roots in the laboratories of great research universities with great science and visionary researchers. These cutting-edge, biology-based research and industry commercialization efforts continue to be the key drivers in moving invention into innovation to heal, fuel and feed the world. Because of this essential knowledge-driven relationship, the 2013 BIO International Convention will again bring together academic and research colleagues to focus Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Flight Flies on 100 Percent Biofuels

falcon-20

This week saw the first-ever completely biofuel-powered flight take place. The National Research Council of Canada conducted the first flight on 100 percent renewable, drop-in biofuel on its Falcon 20 jet, according to oilprice.com, marking a huge milestone for the aviation and renewable energy industries. Oilseed crops commercialized by Agrisoma were used as a feedstock and transformed by Applied Research Associates into a complete replacement fuel for conventional jet fuel. Previously, flights on biofuels had Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

SIPO Examiner Workshop: Biotech Patent Practices in the U.S., China and Japan

Great Wall of China - Image by jrover

The biotechnology industry is an invention-intensive industry that relies heavily on the protection of intellectual property, especially patent rights. Patent protection is territorial, and patent practice varies in different jurisdictions. Many foreign biotech companies continue to look at China as an important emerging market, and they increasingly file patent applications in China to develop their global patent portfolios. At the same time, China has made biotechnology one of the eight strategic new technology focuses in Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

“When Genetic Engineering Came Of Age”

insulin

October 29 was the 30th anniversary of the approval by the Food and Drug Administration (FDA) of human insulin synthesized in genetically engineered bacteria. In an article for Forbes, Henry Miller, the founding director of the FDA’s Office of Biotechnology, marked the anniversary and commented on today’s regulatory environment: “Regulators have adopted a highly risk-averse and even adversarial mindset, few new drugs are approved without convening extramural advisory committees, and decisions are sometimes hijacked by Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Biotech Patenting Event: BIO’s 2012 Fall IPCC in Charleston, South Carolina

charleston

BIO’s 2012 Fall IPCC Conference event on November 12-14 gathers biotech in-house counsels to provide and discuss relevant IP developments.  The Honorable Jimmie V. Reyna, Circuit Judge for the United States Court of Appeals for the Federal Circuit keynotes this year’s program along with the Honorable Judge Sally Gardner Lane, Administrative Patent Judge, Trial Division, Board of Patent Appeals and Interferences. Find program topics and speakers below.  Click here for the full agenda.   Picking the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,